REACH-OUT (Research,Engagement and Action on COVID-19HealthOutcomesviaTesting)
Project Number1U01MD017436-01
Former Number1U01AG077374-01
Contact PI/Project LeaderDECAMP, MATTHEW WAYNE Other PIs
Awardee OrganizationUNIVERSITY OF COLORADO DENVER
Description
Abstract Text
PROJECT ABSTRACT
As the coronavirus disease 2019 (COVID-19) pandemic evolves, equitable access to SARS-CoV testing and
contact tracing will be critical to ongoing pandemic surveillance. Even as COVID-19 infection rates,
hospitalizations, and deaths are declining overall, testing will be necessary to identify people who may benefit
from COVID-19 therapies, to encourage isolation and quarantine of close contacts to prevent spread, to
monitor for real-world vaccine effectiveness, and to learn about how the virus may be spreading within
communities. For those communities disproportionately affected by COVID-19, testing may be simultaneously
more important and yet more challenging because of the social, ethical, and behavioral implications (SEBI) of a
positive test. Fears of positive tests leading to lost wages, employment disruption, privacy breaches, or
housing instability can deter testing and contact tracing. In some communities, structural barriers, mistrust, or
other factors may have contributed to vaccine hesitancy or lower rates of vaccination – circumstances that
create greater potential for bias, discrimination, and stigmatization of communities where future COVID-19
outbreaks or may occur. The goal of REACH-OUT (Research,Engagement and Action on COVID-19HealthOutcomesviaTesting) is to improve the reach, uptake and sustainability of COVID-19testing among 5
underserved and socially- or medically-vulnerable populations via a community-based, participatory action
research approach. Our project builds upon the strong community engagement network infrastructure built by
the Colorado Community Engagement Alliance Against COVID-19 Disparities (CO-CEAL) and an existing
Phase I SEBI grant (CONCERTS; Community Organizations for Natives: COVID-19 Epidemiology, Research,Testing, and Services). It broadens and deepens these efforts to address the next phase of the pandemic.
This unique partnership between communities and multidisciplinary academic researchers with expertise in
bioethics, mixed methods research, intervention design, and public health evaluation will: (1) engage
communities to rapidly understand key cultural beliefs, communication preferences, and community-level
resources that can be leveraged to overcome social, ethical, and behavioral barrier to COVID-19testing using
mixed methods; (2) co-create and implement a menu of culturally-concordant strategies at the individual,
interpersonal, health system, and/or community levels to increase testing rates, contact tracing, and access to
COVID-19 support services using an Intervention Mapping approach; and (3) evaluate the processes and
testingoutcomes from REACH-OUT to inform the COVID-19 response and responses to future pandemics
(including evaluation of the engagement process itself). We will focus on 5 populations (American
Indian/Alaska Native; Urban LatinX; Rural LatinX; Urban Black or African American; and Black/Refugee),
enabling us to draw comparative insights about the barriers in common and unique to each and – in
coordination with other SEBI projects – to generalize our findings to other communities throughout the US.
Public Health Relevance Statement
PROJECT NARRATIVE
As the coronavirus disease 2019 (COVID-19) pandemic continues to evolve, testing and contact tracing will
remain critical to ongoing prevention of serious illness, death, and the social, economic and other ill-effects of
the virus. For millions of Americans living in communities disproportionately affected by COVID-19, testing is
essential and yet complicated by social, ethical, and behavioral implications – such as concerns about
employment status, privacy, stigma, mistrust, and bias – that can deter testing. This community-based project
will engage five communities to design, implement, and evaluate interventions to address these concerns.
.
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
041096314
UEI
MW8JHK6ZYEX8
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$556,041
Direct Costs
$428,468
Indirect Costs
$127,573
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$556,041
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017436-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017436-01
Patents
No Patents information available for 1U01MD017436-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017436-01
Clinical Studies
No Clinical Studies information available for 1U01MD017436-01
News and More
Related News Releases
No news release information available for 1U01MD017436-01
History
No Historical information available for 1U01MD017436-01
Similar Projects
No Similar Projects information available for 1U01MD017436-01